LiVeritas Biosciences enables biopharma companies to fast track drug research & development (R&D) process through mass spectrometry (MS) and digital transformation. We offer unparalleled sense of urgency and quality of work to empower our partners in delivering patient-centric outcomes through:
• Curated analytical test packages effective in rapidly advancing drug candidates in the development pipeline including (1) drug design optimization, (2) process development and characterization, (3) accelerating novel drug candidates path to Investigational New Drug (IND)
• Partner-centric software solutions that streamlines analytical operations, CMC strategies, and drug product knowledge management; and
• Industry expertise with milestone focused biotech startup backgrounds grounded in big biopharma core competencies.